对于BRAFV600突变黑色素瘤的当前和新兴治疗选择
Anadil Javaid1, Tobias Peres1, Javier Pozas1
1Skin and Renal Unit, Royal Marsden Hospital, London, United Kingdom.
Expert review of anticancer therapy
|January 9, 2025
概括
治疗BRAF突变黑色素瘤的进展为人们提供了新的希望. 向治疗和免疫检查点抑制剂是关键,但早期和晚期的挑战需要进一步研究以获得最佳的患者护理.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 医学研究 医学研究
背景情况:
- BRAF突变导致40%的皮肤黑色素瘤病例.
- 针对BRAF的向治疗 (TT) 和免疫检查点抑制剂 (ICI) 是BRAF突变黑色素瘤的支柱.
- 治疗策略存在于新辅助,辅助和高级设置.
研究的目的:
- 审查关于BRAF突变黑色素瘤管理的当前文献.
- 确定BRAF突变黑色素瘤治疗的挑战和未来研究领域.
主要方法:
- 关于BRAF突变类型和抵抗机制的文献综述.
- 对新辅助,辅助和先进治疗方法的分析.
- 确定未解决的临床问题和研究缺口.
主要成果:
- 重要的文献指导了BRAF突变黑色素瘤的管理.
- 关键的挑战仍然存在于特定的患者群体和环境中.
- 需要进一步研究生物标志物和治疗缓解.
结论:
- 虽然已知很多,但对某些BRAF突变黑色素瘤患者群体的最佳管理仍然存在争议.
- 需要进一步的研究来完善治疗策略,并确定预测生物标志物.
- 解决剩余的问题将改善BRAF突变黑色素瘤的临床决策.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Vaccines
337
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
337
Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


